Startseite Cystatin C: current position and future prospects
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Cystatin C: current position and future prospects

  • Sophie Séronie-Vivien , Pierre Delanaye , Laurence Piéroni , Christophe Mariat , Marc Froissart , Jean-Paul Cristol und for the SFBC “Biology of renal function and renal failure” working group
Veröffentlicht/Copyright: 1. Dezember 2008
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Cystatin C is a low-molecular-weight protein which has been proposed as a marker of renal function that could replace creatinine. Indeed, the concentration of cystatin C is mainly determined by glomerular filtration and is particularly of interest in clinical settings where the relationship between creatinine production and muscle mass impairs the clinical performance of creatinine. Since the last decade, numerous studies have evaluated its potential use in measuring renal function in various populations. More recently, other potential developments for its clinical use have emerged. This review summarises current knowledge about the physiology of cystatin C and about its use as a renal marker, either alone or in equations developed to estimate the glomerular filtration rate. This paper also reviews recent data about the other applications of cystatin C, particularly in cardiology, oncology and clinical pharmacology.

Clin Chem Lab Med 2008;46:1664–86.


Corresponding author: Sophie Séronie-Vivien, Département de Biologie Clinique, Institut Claudius Regaud (CRLCC Midi-Pyrénées), 20–24 rue du Pont St. Pierre, 31052, Toulouse Cedex, France Phone: +33-5-61424221, Fax: +33-5-61424631,

Received: 2008-5-26
Accepted: 2008-8-18
Published Online: 2008-12-01
Published in Print: 2008-12-01
Published in Print: 2008-10-31

©2008 by Walter de Gruyter Berlin New York

Artikel in diesem Heft

  1. Editors' and Publisher's Note
  2. CCLM Award for the most cited paper recently published
  3. Reviews
  4. Cystatin C: current position and future prospects
  5. Some heterogeneity factors affecting the B-type natriuretic peptides outcome: a meta-analysis
  6. Genetics and Molecular Diagnostics
  7. Effect of cyclin D1 (CCND1) polymorphism on gastric premalignant condition
  8. Identification of two de novo mutations in Chinese patients with X-linked adrenoleukodystrophy
  9. CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: high regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation
  10. Apolipoprotein A5 gene −1131T/C polymorphism is associated with the risk of metabolic syndrome in ethnic Chinese in Taiwan
  11. Association of GSTM1 and GSTT1 gene polymorphisms with coronary artery disease in relation to tobacco smoking
  12. Use of the biochip microarray system in detection of myocardial injury caused by radiofrequency catheter ablation
  13. An in-house method for the detection and quantification of HCV in serum samples using a TaqMan assay real time PCR approach
  14. General Clinical Chemistry and Laboratory Medicine
  15. Drugs and brain death diagnostics: determination of drugs capable of inducing EEG zero line
  16. Accurate assessment and identification of naturally occurring cellular cobalamins
  17. Development and validation of a high-performance liquid chromatography assay for posaconazole utilizing solid-phase extraction
  18. Discriminant value of % microcytic/% hypochromic ratio in the differential diagnosis of microcytic anemia
  19. Determination of carbohydrate-deficient transferrin (CDT) in Italy
  20. Validation and Outcome Studies
  21. Critical evaluation of connectivity-based point of care testing systems of glucose in a hospital environment
  22. Validation of a novel ELISA for measurement of electronegative low-density lipoprotein
  23. Five commercially available insulin-like growth factor I (IGF-I) assays in comparison to the former Nichols Advantage IGF-I in a growth hormone treated population
  24. Introduction of non-linearity by data transformation in method comparison and commutability studies
  25. Reliability and correlation study of a new homocysteine assay
  26. Letters to the Editor
  27. Prevention of preanalytical false-positive increases of cardiac troponin I on the Unicel® DxI 800 analyzer
  28. Does carbamylated hemoglobin still affect the analysis of HbA1c in uremic and hyperglycemic patients?
  29. Recombinant immunoblot for assessment of intrathecally synthesised paraneoplastic antineuronal antibodies in cerebrospinal fluid from patients with paraneoplastic neurological syndromes
  30. Detection of duplicates and redundancies. A major responsibility of peer-reviewers?
  31. Erratum
  32. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome
  33. Acknowledgement
  34. Acknowledgements
  35. Contents
  36. Contents, Volume 46, 2008
  37. Author Index
  38. Author Index
  39. Subject Index
  40. Subject Index
Heruntergeladen am 24.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.336/html
Button zum nach oben scrollen